In a trial from China, 165 people suffering from advanced NSCLC who had EGFR exon 20 insertional mutations were included, and a total of 39 molecular variant types were identified, with the V796_D770insASV and D770_N771insSVD being the most prevalent mutations observed [31]. Here, EGFR is linked to non-small cell lung carcinoma.